Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep

Journal of Endocrinology

Volumn 204, Issue 2, 2010, Pages 181-189

  Charles, Christopher J ^a   Jardine, David L ^a   Rademaker, Miriam T ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; HEXAMETHONIUM; NORADRENALIN; UROCORTIN II;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; HEART; HEART OUTPUT; HEART RATE; HEMODYNAMICS; INHIBITION KINETICS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SHEEP; SYMPATHETIC NERVE; VASCULAR RESISTANCE;

ANIMALS; BAROREFLEX; CATECHOLAMINES; CONSCIOUSNESS; FEMALE; GANGLIONIC BLOCKERS; HEXAMETHONIUM; SHEEP; SYMPATHETIC NERVOUS SYSTEM; UROCORTINS;

EID: 75149173528     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0505     Document Type: Article

References (33)

1. Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW & Peterson KL 2004 The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. PNAS 101 3697-3702.
2. Boonprasert P, Lailerd N & Chattipakorn N 2008 Urocortins in heart failure and ischaemic heart disease. International Journal of Cardiology 127 307-312.
3. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjos OD, Latchman DS, Lee KF & Vale W 2004 Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotrophin releasing factor receptor type 2 in the murine heart. Endocrinology 145 24-35.
4. Charles CJ, Rademaker MT & Richards AM 2004 Urocortins: putative role in cardiovascular disease. Current Medicinal Chemistry - Cardiovascular and Hematological Agents 2 43-47.
5. Charles CJ, Jardine DL, Nicholls MG, Rademaker MT & Richards AM 2008 Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in conscious sheep. Journal of Hypertension 26 53-60.
6. Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT & Richards AM 2007a Urocortin 2 infusion in healthy humans. Journal of the American College of Cardiology 49 461-471.
7. Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT & Richards AM 2007b Urocortin 2 infusion in human heart failure. European Heart Journal 28 2589-2597.
8. De Fanti BA & Martinez JA 2002 Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Research 930 37-41.
9. Dermitzaki E, Tsatsanis C, Minas V, Chatzaki I, Charalampopoulos I, Venihaki M, Androulidaki A, Lambropoulou M, Spiess J, Michalodimitrakis E et al. 2007 Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Endocrinology 148 1524-1538.
10. Fekete EM & Zorilla EP 2007 Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Frontiers in Neuroendocrinology 28 1-27.
11. Gardiner SM, March JE, Kemp PA & Bennett T 2007 A comparison between cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats. Journal of Pharmacology and Experimental Therapeutics 321 221-226.
12. Goldstein DS, Feuerstein G, Izzo JL, Kopin IJ & Keiser HR 1981 Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sciences 28 267-275.
13. Hays FL &Webster AJF 1971 Effects of cold, eating, efferent nerve stimulation and angiotensin on heart rate in sheep before and after autonomic blockade. Journal of Physiology 216 21-38.
14. Hsu SY & Hsueh AJ 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Medicine 7 605-611.
15. Jardine DL, Charles CJ,Melton IC,May CN, Forrester MDE, Frampton CM, Bennett SI & Ikram H 2002 Continual recording of cardiac sympathetic nerve activity in conscious sheep. American Journal of Physiology 282 H93-H99.
16. Kastin AJ & Akerstrom V 2002 Differential interactions of urocortin/ corticotrophin-releasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75 367-374.
17. Koob GF & Heinrichs SC 1999 A role for corticotrophin releasing factor and urocortin in behavioural responses to stressors. Brain Research 848 141-152.
18. Lewis K, Li C, Perrin MH, Blount A, Kunitake KS, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W et al. 2001 Identification of urocortin III, an additional member of the corticotrophin-releasing factor (CRF) family with high affinity for the CRFR2 receptor. PNAS 98 7570-7575.
19. Lumbers ER & Yu ZY 1999 A method for determining baroreflex-mediated sympathetic and parasympathetic control of the heart in pregnant and non-pregnant sheep. Journal of Physiology 515 555-566.
20. Malpas SC & Coote JH 1994 Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. American Journal of Physiology 266 R228-R236.
21. Malpas SC & Ninomiya I 1992a The amplitude and periodicity of synchronized renal sympathetic nerve discharges in anesthetized cats: differential effect of baroreceptor activity. Journal of the Autonomic Nervous System 40 189-198.
22. Malpas SC & Ninomiya I 1992b Effect of chemoreceptor stimulation on the periodicity of renal sympathetic nerve activity in anesthetized cats. Journal of the Autonomic Nervous System 37 19-28.
23. Nemoto T, Mano-Otagiri A & Shibasaki T 2005 Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells. Biochemical and Biophysical Research Communications 330 821-831.
24. Ninomiya I, Nisimaru N & Irisawa H 1971 Sympathetic nerve activity to spleen, kidney and heart in response to baroreceptor input. American Journal of Physiology 221 1346-1351.
25. Pagani M, Schwartz PJ, Banks R, Lombardi F & Malliani A 1974 Reflex responses to sympathetic preganglionic neurones initiated by different cardiovascular receptors in spinal animals. Brain Research 68 215-225.
26. Parkes D & May C 1999 Cardiac and vascular actions of urocortin. In Hormones and the Heart in Health and Disease, pp 39-52. Ed. L Share. Humana Press: NJ, USA.
27. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CM, Lainchbury JG, Nicholls MG, Richards AM & ValeWW 2002 Beneficial hemodynamic, endocrine and renal effects of urocortin in experimental heart failure: comparison with normal sheep. Journal of the American College of Cardiology 40 1495-1505.
28. Rademaker MT, Cameron VA, Charles CJ & Richards AM 2005 Integrated hemodynamic, hormonal and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112 3624-3632.
29. RademakerMT, Cameron VA, Charles CJ & Richards AM 2006 Urocortin 3: hemodynamic, hormonal and renal effects in experimental heart failure. European Heart Journal 27 2088-2098.
30. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WWet al. 2001 Urocortin II: a member of the corticotrophin-releasing factor (CRF) family that is selectively bound by type 2 CRF receptors. PNAS 98 2843-2848.
31. Saper CB, Loewy AD, Swanson LW & Cowan WM 1976 Direct hypothalamo-autonomic connections. Brain Research 117 305-312.
32. Sundlof G & Wallin BG 1978 Human muscle nerve sympathetic activity at rest: relationship to blood pressure and age. Journal of Physiology 274 621-637.
33. Wiley KE & Davenport AP 2004 CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. British Journal of Pharmacology 143 508-514.